BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3859321)

  • 1. A myelodysplastic syndrome preceding acute lymphoblastic leukaemia.
    Berneman ZN; Van Bockstaele D; De Meyer P; Van der Planken M; Vertessen F; De Bock R; Peetermans ME
    Br J Haematol; 1985 Jun; 60(2):353-4. PubMed ID: 3859321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of biscoclaurine alkaloids, prednisolone and ascorbic acid on myelodysplastic syndrome with pancytopenia: a case report.
    Saito N; Miyamoto M; Gotoh U; Yoshitomi S
    Eur J Haematol; 2000 Jan; 64(1):61-5. PubMed ID: 10680708
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute biphenotypic leukaemia (myeloid and null-ALL type) supervening in a myelodysplastic syndrome.
    Eridani S; Chan LC; Halil O; Pearson TC
    Br J Haematol; 1985 Nov; 61(3):525-9. PubMed ID: 3864486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case with pancytopenia: the role of cytomorphology.
    Sukrisman L; Mulansari NA; Sudoyo AW
    Acta Med Indones; 2013 Jan; 45(1):67-8. PubMed ID: 23585412
    [No Abstract]   [Full Text] [Related]  

  • 5. Pseudo-Chédiak-Higashi anomaly.
    Gallardo R; Kranwinkel RN
    Am J Clin Pathol; 1985 Jan; 83(1):127-9. PubMed ID: 3966432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancytopenia secondary to lymphoid leukemia in three horses.
    Lester GD; Alleman AR; Raskin RE; Meyer JC
    J Vet Intern Med; 1993; 7(6):360-3. PubMed ID: 8114032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a scoring system to establish the probability of myelodysplastic syndrome in patients with unexplained cytopenias or macrocytosis.
    Rauw J; Wells RA; Chesney A; Reis M; Zhang L; Buckstein R
    Leuk Res; 2011 Oct; 35(10):1335-8. PubMed ID: 21704372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic cytopenia of undetermined significance and the minimal criteria for a diagnosis of myelodysplastic syndrome.
    Pavlu J; Emmerson J; Marks AJ; Bain BJ
    Leuk Lymphoma; 2011 Mar; 52(3):515-6. PubMed ID: 21323527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of the haematologic spectrum of myelodysplastic syndrome.
    Kini J; Khadilkar UN; Dayal JP
    Indian J Pathol Microbiol; 2001 Jan; 44(1):9-12. PubMed ID: 12561987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow biopsy in patients with hepatitis C virus infection: spectrum of findings and diagnostic utility.
    Klco JM; Geng B; Brunt EM; Hassan A; Nguyen TD; Kreisel FH; Lisker-Melman M; Frater JL
    Am J Hematol; 2010 Feb; 85(2):106-10. PubMed ID: 20095034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelodysplastic syndrome with myelofibrosis: myelodysplastic syndrome as a major primary disorder for acute myelofibrosis.
    Takahashi M; Koike T; Nagayama R; Fujiwara M; Koyama S; Ohnishi M; Nakamori Y; Soga N; Aoki S; Tatewaki W
    Clin Lab Haematol; 1991; 13(1):17-23. PubMed ID: 2060260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of Sézary syndrome and dysmyelopoiesis with an excess of myeloblasts.
    Rostoker G; Raphael M; Boisnick S; Charron D
    J Am Acad Dermatol; 1986 Dec; 15(6):1296-8. PubMed ID: 3805369
    [No Abstract]   [Full Text] [Related]  

  • 13. The aplastic presentation of childhood leukaemia: a feature of common-ALL.
    Breatnach F; Chessells JM; Greaves MF
    Br J Haematol; 1981 Nov; 49(3):387-93. PubMed ID: 6945869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sweet's syndrome and myelodysplasia: two entities with a common pathogenetic mechanism? A case report.
    Zappasodi P; Corso A; del Forno C
    Haematologica; 2000 Aug; 85(8):868-9. PubMed ID: 10942935
    [No Abstract]   [Full Text] [Related]  

  • 15. Gaucher disease, myelodysplastic syndrome and ICUS.
    Ruchlemer R; Mittelman M; Zimran A
    Blood Cells Mol Dis; 2020 Feb; 80():102373. PubMed ID: 31718920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of a myelodysplastic syndrome to pre-B acute lymphoblastic leukaemia with unusual phenotype.
    Bonati A; Delia D; Starcich R
    Br J Haematol; 1986 Nov; 64(3):487-91. PubMed ID: 3539173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow histology. 3: Value of bone marrow core biopsy in acute leukaemia, myelodysplastic syndromes, and chronic myeloid leukaemia.
    Winfield DA; Polacarz SV
    J Clin Pathol; 1992 Oct; 45(10):855-9. PubMed ID: 1430254
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pattern analytic investigations of blast cells in myelodysplastic syndrome and secondary acute myeloid leukemia].
    Baumann I; Harms H; Kuse R; Feller AC; Müller-Hermelink HK
    Verh Dtsch Ges Pathol; 1990; 74():135-8. PubMed ID: 1708571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evolution of acute leukemia in myelodysplastic syndromes: prognostic histopathological factors in a series of bone marrow biopsies].
    Navone R; Ranco V; Pich A
    Pathologica; 1991; 83(1083):55-63. PubMed ID: 1866200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azacytidine for the treatment of myelodysplastic syndromes in the elderly.
    Diez Campelo M; Delgado RG; Molias AC; Sanchez JF
    Adv Ther; 2011 Mar; 28 Suppl 2():10-5. PubMed ID: 21431505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.